ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 935,77
-1,51%
Dow Jones
38 513,08
-0,87%
DAX
18 470,69
-1,15%
Brent Oil
83,585
-0,88%
Bitcoin
67 714,18
-0,84%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Inhibitor Therapeutics Inc (QB) (INTI)

  7. Inhibitor Therapeutics Inc (QB) (INTI) Actualités

INTI

Inhibitor Therapeutics (QB) (INTI)

Inhibitor Therapeutics Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:INTI
DateHeureSourceTitreSymboleSociété
16/05/202419h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
13/05/202415h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INTIInhibitor Therapeutics Inc (QB)
14/12/202312h02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
29/08/202320h42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
31/05/202322h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
23/05/202318h50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:INTIInhibitor Therapeutics Inc (QB)
22/05/202321h45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202312h02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202301h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
15/05/202315h04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
30/03/202215h02Edgar (US Regulatory)Annual Report (10-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
10/02/202022h21Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:INTIInhibitor Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:INTI

Dernières Valeurs Consultées

BIT
F19763
Vontobel Financial Produ...
ASX
PARN
Paradigm Biopharmaceutic...
USOTC
WEIIF
Wolverine Energy and Inf... (CE)
COIN
RATINGETH
DPRating
TG
EKT
Energiekontor
TG
PAH3
Porsche Automobil
USOTC
WTBFA
WTB Financial (PK)
BIT
F12014
Vontobel Financial Produ...
USOTC
FCHS
First Choice Healthcare ... (PK)
LSE
CIAB
Close Iht Aim Vct
USOTC
MTYFF
Mty Food (PK)
NASDAQ
SQFTP
Presidio Property
BIT
SMARTU
ETF
NASDAQ
QOWZ
Invesco Nasdaq Free Cash...
USOTC
ARDDF
Ardiden (PK)
EU
UEF5
UBS Lux Fund Solutions M...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés